News

                        Array
(
    [0] => stdClass Object
        (
            [id] => 1204
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => ca8101c32ea98ff7d6b8.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-05-06
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-05-06 15:45:02
            [updated_time] => 2024-09-04 08:53:57
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Gentis-Main-sponsor-of-the-24th-Vietnam-France-Asia-Pacific-Obstetrics-and-gynecology-conference
            [title] => GENTIS - Main Sponsor of the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference
            [description] => The Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference, organized by Tu Du Hospital, is a significant event to obstetrics and gynecology experts. The conference provides opportunities for experts within the country and abroad to meet, exchange experiences related to diagnosis, treatment, research, and development in the field of obstetrics and gynecology.


            [content] => 
GENTIS is proud to have been accompanying the symposium over the years. In 2024, GENTIS is honored to be one of the main sponsors, partnering with Tu Du Hospital and contributing to the success of the symposium.
As a sponsor, GENTIS will introduce testing products related to assisted reproduction, obstetrics, and pediatrics, notably the PGT-M test, NIPT GenEva, and newborn screening. Additionally, visitors to the GENTIS booth will receive hundreds of valuable gifts.
 
The event will take place from May 9-10, 2024, at Riverside Palace Conference Center, 360D Ben Van Đon, Ward 1, District 4, Ho Chi Minh City. Don’t miss the opportunity to attend the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference on May 9-10, 2024!
GENTIS looks forward to welcoming and collaborating with esteemed doctors and experts at the conference
            [content_more] => 
            [meta_title] => GENTIS - Main Sponsor of the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Confer
            [meta_description] => The Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference, organized by Tu Du Hospital, is a significant event to obstetrics and gynecology experts
            [meta_keyword] => GENTIS,Obstetrics,Sponsor,Conference
            [thumbnail_alt] => 
            [post_id] => 1204
            [category_id] => 4
        )

    [1] => stdClass Object
        (
            [id] => 1201
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => cea85afa150abb54e21b.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-04-26
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-04-26 13:18:37
            [updated_time] => 2024-09-04 14:22:05
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 1
            [is_table_content] => 0
            [language_code] => en
            [slug] => Talk-show-genetic-counseling-for-pgt-m-screening-for-embryonic-monogenic-diseases-international-recommendations-and-practices-in-vietnam
            [title] => TALK SHOW: "GENETIC COUNSELING FOR PGT-M SCREENING FOR EMBRYONIC MONOGENIC DISEASES: INTERNATIONAL RECOMMENDATIONS AND PRACTICES IN VIETNAM"
            [description] => On April 24, GENTIS Genetic Counseling Center broadcasted the 2nd Genetic Counseling - Expert Consultation Talkshow with the topic: "Genetic counseling for PGT-M testing for screening for embryonic monogenic diseases: International recommendations and practices in Vietnam" on the fanpage of GENTIS. The conversation took place successfully and attracted a lot of attention from doctors working in the field of assisted reproduction as well as couples who are in need of IVF.

            [content] => 
At the talk show, Assoc.Prof.Tran Van Khoa, PhD.,MD., (Head of the Department of Biology - Genetics, Military Medical Academy), Pham Dinh Minh, PhD., (R&D Director of GENTIS - Director of GENTIS Genetic Counseling Center), Nguyen Thi Huyen, MSc.,MD. (Genetic Consultant at GENTIS Genetic Counseling Center - GENTIS R&D Specialist) shared their knowledge about PGT-M, international recommendations and the practical situation of implementing this test in Vietnam in very close and easy-to-understand real stories.

Sharing about the significance of the PGT-M test with couples who are expecting children and want to perform IVF, Assoc.Prof.Tran Van Khoa, PhD.MD. said: "PGT-M is one of the most effective, most active, and earliest preventive screening measures to prevent genetic diseases. PGT-M is also a hope for couples who are unfortunate enough to carry the disease gene and are at risk of bearing a child affected."
Pham Dinh Minh, PhD. added: "Currently, most genetic diseases, especially those caused by genetic mutations, still have no treatment, if any, the price is also very high, difficult to access, causing burdens for patients' families and society. Therefore, screening and prevention of these diseases has become very important."
It can be seen that the advancement of gene sequencing technology has brought advanced solutions that greatly help the preimplantation screening process, and PGT-M is one of the most effective and outstanding solutions.
Both Assoc. Prof. Khoa and Dr. Minh agreed that: "PGT-M is a difficult test, requiring investment in advanced scientific technologies and equipment to ensure accuracy." With a laboratory system that meets ISO 13485:2016, ISO 15189:2012 standards, along with modern machines equipped with the latest technologies, GENTIS is one of the few testing centers that can perform qualified PGT-M tests, ensuring high accuracy and optimal turnaround time. From there, it helps to screen for monogenic genetic diseases effectively and provide maximum support for reproductive support purposes.
"To ensure the most accurate PGT-M test results, it is necessary to have a combination of clinicians, genetic consultants, embryologists and testing labs. GENTIS has established the Genetic Counseling Center to support clinicians and embryologists to use and understand the test in the best way" - Dr. Minh emphasized.
"Genetic counseling is often carried out in clinics, hospitals, and centers by geneticists and assisted reproductive doctors. Genetic counseling revolves around the exchange between doctors and patients, in order to provide information for doctors to identify general and genetic risks, evaluate, consider, select appropriate tests, and find out the underlying cause of the disease. The most important thing is that the genetic counseling process must ensure that three factors are accurate, complete and most suitable for the patient. The ultimate goal is that patients can participate in the treatment process and make treatment decisions that are suitable for their family circumstances," added Nguyen Thi Huyen, MSc.MD..
In addition, Dr. Huyen and experts also answered a lot of questions from the audience about monogenic genetic diseases. These are all valuable knowledge that is summarized and explained in the most understandable way for everyone.
Hopefully, the sharing of experts in the talk show will help doctors and nurses working in the field of assisted reproduction gain a lot of useful updated knowledge. At the same time, it brings a new hope to couples who unfortunately carry the disease gene and are looking forward to having children.
            [content_more] => 
            [meta_title] => TALK SHOW: "GENETIC COUNSELING FOR PGT-M SCREENING FOR EMBRYONIC MONOGENIC DISEASES:
            [meta_description] => GENTIS Genetic Counseling Center broadcasted the 2nd Genetic Counseling - Expert Consultation Talkshow with the topic: "Genetic counseling for PGT-M testing for screening for embryonic monogenic diseases: International recommendations and practices in Vie
            [meta_keyword] => genetic conseling,pgt-m,test,gentis
            [thumbnail_alt] => 
            [post_id] => 1201
            [category_id] => 4
        )

    [2] => stdClass Object
        (
            [id] => 1200
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => c8f9f57fb9f016ae4fe1.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-04-08
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-04-09 08:29:51
            [updated_time] => 2024-09-04 09:10:43
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Gentis-in-collaboration-with-the-high-quality-general-hospital-of-thai-binh-for-the-obstetrics-workshop
            [title] => GENTIS in collaboration with the High-Quality General Hospital of Thai Binh for the Obstetrics workshop
            [description] => Recently, the High-Quality General Hospital of Thai Binh has successfully conducted the Obstetrics Workshop with the topic: “Vaginal delivery or Cesarean section - Why?” The event has conveyed valuable knowledge as well as unforgettable memories for more than 30 guests including pregnant mothers and their families. GENTIS is honored to have collaborated with the workshop and presented meaningful gifts to the mothers.
            [content] => 
he decision between vaginal birth and cesarean section (C-section) has always been a common dilemma for expectant mothers, especially for first-time mothers. To equip expectant mothers with the scientific knowledge needed for a healthy pregnancy stage and ensure a safe delivery, Thai Binh High-Quality General Hospital organized an Obstetrics Workshop on the topic: "Vaginal Birth or Cesarean Section - Why?"

The keynote speaker of the event was Specialist level 1 Tran Thi Thanh, MD., Deputy Head of the Obstetrics Department at Thai Binh Hospital. At the event, Dr. Thanh shared detailed information about the two childbirth methods (vaginal birth and C-section), providing expectant mothers with a comprehensive overview. This helped them choose the birth method most appropriate in terms of physical health for both the mother and the fetus."

According to obstetrics experts, vaginal delivery offers more benefits to both mother and baby compared to C-section. Therefore, doctors always encourage healthy pregnant women to have a vaginal delivery.
Just in cases where pregnant women have medical conditions that inhibit a vaginal birth, it is necessary to follow the advice of a specialist to ensure a healthy mother and baby. Regardless of the chosen birth method, mothers need to cooperate well with doctors during labor to ensure a smooth and safe delivery. Additionally, Dr. Thanh also emphasized the significance of newborn screening tests for babies.

Currently, newborn screening is considered the most efficient method for early abnormalities detection, allowing timely intervention to prevent complications and damage. Additionally, this test also increases survival rates, diminishes the impact of diseases, and helps prolong patient lifespan. Simultaneously, it helps to save healthcare costs by enabling early detection.
Not only did the workshop provide mothers with solid knowledge from Dr. Thanh, but it also served as a warm and intimate gathering where mothers could share their inner thoughts and hidden feelings through daily stories around their pregnancy journey. Notably, expectant mothers were able to directly ask questions and receive answers from the doctor. Hopefully, this valuable knowledge will empower mothers to feel more confident in caring for themselves and their babies.

In addition, when attending the workshop, mothers also had the opportunity to receive appealing gifts from the hospital, GENTIS and other brands. Coming to the program, GENTIS has brought valuable gifts to bring joy and meaningfulness to parents. These include adorable teddy bears and a 50% discount voucher for a newborn screening test covering 83 diseases, covering 5 center diseases (congenital hypothyroidism, G6PD deficiency, congenital adrenal hyperplasia, phenylketonuria, galactosemia), Hemoglobinopathies, as well as 77 metabolic disorders.

GENTIS would like to express our sincere gratitude to High-Quality General Hospital of Thai Binh for allowing us to partake in this meaningful event. We hope that with the speaker’s sharing, mothers would be more confident in their journey to welcoming their babies, while also having a better understanding of the importance of newborn screening. We look forward to continued support from you.
            [content_more] => 
            [meta_title] => GENTIS in collaboration with the High-Quality General Hospital of Thai Binh for the Obstetrics works
            [meta_description] => Recently, the High-Quality General Hospital of Thai Binh has successfully conducted the Obstetrics Workshop with the topic: “Vaginal delivery or Cesarean section - Why?”
            [meta_keyword] => GENTIS,workshop,collaboration
            [thumbnail_alt] => 
            [post_id] => 1200
            [category_id] => 4
        )

    [3] => stdClass Object
        (
            [id] => 1197
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => z5288948524713_e3c8a0be95d08dfe06764da781ae3eb6.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-04-04
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-04-04 09:44:09
            [updated_time] => 2024-08-28 14:42:36
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Genetic-counseling-in-the-era-of-genomics-and-personalized-medicine
            [title] => Genetic Counseling in the Era of Genomics and Personalized Medicine
            [description] => Precision medicine and personalized medicine are now widely applied in the field of Assisted Reproductive Technology (ART) in countries with advanced healthcare systems. This is an inevitable trend in disease management. Based on the test results and clinical conditions of each patient, genetic counselors provide information that helps patients better understand their condition, make informed decisions, and access other necessary medical services.

            [content] => 
The Benefits of Precision Medicine and personalized medicine in the Field of ART 
Precision medicine and personalization are  revolutionizing the  field of ART. This approach offers numerous benefits, enabling us to treat the right patient, at the right time, with the right drug, at the right dose. As a result, it minimizes unwanted side effects and reduces unnecessary trials.
Moreover, precision medicine and personalized medicine also help to reduce treatment time and costs for patients. Patients are actively involved in their own treatment process, gaining a better understanding of their condition and participating in selecting more suitable treatment options. Additionally, the shifting from treatment to prevention, in other words, personalized medicine helps us prioritize prevention over cure.
The core of these methods lies in genetic testing. Due to advancements in technology, genetic testing has become increasingly integrated with precision medicine, making it an indispensable part of the field of assisted reproduction. Genetic testing plays a crucial role in all stages of the reproductive process, including testing related to parents, embryos, during embryo transfer, prenatal screening and diagnosis, as well as newborn screening and postnatal diagnosis.
In reproductive medicine, genetic testing is particularly conducted for three main purposes. These are identifying the causes of infertility, detecting genetic diseases that may be passed on to the child, and optimizing assisted reproductive technology (ART). Depending on the specific condition, patients may need to undergo testing at any stage of the reproductive process.
GENTIS applies the latest devices and technologies in gene sequencing to deliver valuable tests to our customers.
In Vietnam, GENTIS is a pioneer in the research and development of genetic tests for the personalization of infertility treatment. GENTIS boasts modern laboratories equipped with Next-Generation Sequencing (NGS) technology, providing accurate results for our customers.
Currently, GENTIS offers a comprehensive ecosystem of genetic tests for screening, diagnosis, and personalized medicine in the field of assisted reproduction. This includes tests for parents, embryos, the embryo transfer environment, and maternal and fetal health.
Among the notable tests are PGT-A/SR, PGT-M, PGT-Max1, ASEM Test, Karyotype, Thalassemia, Thrombophilia, Fertiscan, Ultragen, AZF, Sperm DNA, Genratest, Antiphospholipid, NIPT-basic/Geneva, and newborn screening, ... In addition to providing genetic tests, GENTIS has established a Genetic Counseling Center to support clinicians and reproductive centers in accurately and effectively interpreting test results.
The Importance of Genetic Counseling in the Genomics Era
MSc. Nguyen Thi Huyen, M.D (R&D Specialist at GENTIS), stated: "In the Genomics era, genetic counseling is involved in all stages of the human reproductive process, from pre-pregnancy, pre-embryo transfer, prenatal, to postnatal stages. Specifically, genetic counseling helps assess the risk of genetic diseases and evaluate and determine genetic patterns for appropriate indications.
Additionally, genetic counseling aids in interpreting genetic results, assessing genetic risks for future generations, and evaluating screening in relatives. It also provides information on the benefits/limitations of genetic tests to clinicians, facilitating discussions and helping to determine more appropriate treatment options."
MSc. Nguyen Thi Huyen, M.D (GENTIS), presented at the Scientific Conference and the 2nd Congress for the 2024-2029 term.
Additionally, genetic counseling plays a crucial role in educating and supporting patients, helping them better understand their condition and make informed decisions. More importantly, it assists patients in accessing other necessary medical services when needed.
Despite its importance in the Genomics era, geneticists still face many challenges when advising patients. For instance, they must explain risks to patients who might then reconsider or lose the opportunity for embryo transfer, and they encounter limited consensus and guidelines on managing results, monitoring pregnancies after test results, and screening relatives. They also face challenges in optimizing costs and time for patients.
Therefore, it is essential to have a coordinated approach involving the expertise of clinical physicians, embryologists, laboratory technicians, and geneticists. Additionally, collaboration with obstetricians and gynecologists is necessary for optimal pregnancy management, and with pediatricians and geneticists for postnatal care.
Despite these challenges, the current achievements indicate that precision medicine and personalization are the future of the medical field, influencing genetic counseling and treatment by physicians. To stay abreast of these developments, GENTIS continuously invests in the latest gene sequencing systems for testing and assisted reproduction, aiming to research, develop, and apply genetic analysis technology in precision medicine.
            [content_more] => 
            [meta_title] => Genetic Counseling in the Era of Genomics and Personalized Medicine
            [meta_description] => Precision medicine and personalized medicine are now widely applied in the field of Assisted Reproductive Technology (ART) 
            [meta_keyword] => GENTIS,GeneticCounseling
            [thumbnail_alt] => 
            [post_id] => 1197
            [category_id] => 4
        )

    [4] => stdClass Object
        (
            [id] => 1196
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-09046.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-03-08
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-03-30 10:35:45
            [updated_time] => 2024-09-04 11:37:05
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => the-coffee-talk-genetic-consulting-in-the-field-of-assisted-reproduction-no-1-pgt-expert-consutation
            [title] => The Coffee Talk: Genetic consulting in the field of assisted reproduction no.1: PGT Expert consultation
            [description] => et's review the full recording of the Coffee talk program that took place on March 2 No. 01 with the topic: PGT expert consultation
            [content] => 
✅The event was chaired by Assoc.Prof. Trinh The Son PhD.MD. - Director of the Military Institute of Clinical Embryo-Histology and Nguyen Khac Han Hoan PhD.MD. - Vice Chairman of the Vietnam Association of Medical Genetics - Head of the Department of Medical Genetics Testing, Tu Du Hospital
✅And the participation of nearly 50 delegates, who are clinicians, embryologists, genetic physicians and laboratory experts
---------
???????? This conversation would answer the following questions:
❓What is the role of cooperation and coordination between Clinicians, Embryologists, Genetics Doctors, and Laboratory Experts in genetic counseling for patients undergoing HTSS, especially when using PGT testing?
❓What is the role of genetic counseling of professional units to provide genetic counseling services for hospitals and clinics?
❓What are the difficulties for doctors to correctly prescribe for testing and advise patients before testing?
❓What are the difficulties of a clinical doctor after reading the test results?
CLICK to watch now with GENTIS!
            [content_more] => 
            [meta_title] => The Coffee Talk:  PGT Expert consultation
            [meta_description] => et's review the full recording of the Coffee talk program that took place on March 2 No. 01 with the topic: PGT expert consultation
            [meta_keyword] => Gentis,pgt,geneticconsulting
            [thumbnail_alt] => 
            [post_id] => 1196
            [category_id] => 4
        )

    [5] => stdClass Object
        (
            [id] => 1195
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => z5288819335015_afbf0fa01aaac5723f23ea8c8ef85a59.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-03-28
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-03-28 16:49:26
            [updated_time] => 2024-09-04 14:04:59
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Rare-diseases-a-major-challenge-for-medicine-in-diagnosis-and-treatment
            [title] => Rare Diseases - A Major Challenge for Medicine in Diagnosis and Treatment
            [description] => Genetic disorders, undiagnosed and rare diseases are on the rise globally. According to the World Health Organization, the mortality rate due to congenital anomalies in children under 5 years old in Vietnam in 2015 was 16%, ranking second only to preterm birth. This poses a significant challenge to the goal of reducing child mortality and alleviating the burden on society.

            [content] => 
This information was shared at the 4th Vietnam - US Conference on Medical Genetics and Rare Diseases, organized by the Vietnam National Hospital of Pediatrics in Hanoi on March 25, 2024.
Currently, there are approximately 6,000 known rare diseases affecting 300 million people worldwide - equivalent to the entire population of the United States. Of these, 80% are genetic in origin, with fewer than 200,000 individuals diagnosed. Due to their rarity and complexity, rare diseases present significant challenges for medicine in terms of diagnosis and treatment.
The 4th Vietnam - US Conference on Medical Genetics and Rare Diseases attracted the participation of over 300 delegates.
In recent years, we have witnessed remarkable technological advancements in the diagnosis and treatment of genetic diseases. Notably, next-generation sequencing (NGS) and enzyme replacement therapy (ERT) have emerged as promising tools. 
To provide updates on the latest diagnoses and treatments for genetic and rare diseases in Vietnam and globally, the Vietnam National Hospital of Pediatrics organized the 4th Vietnam - US Conference on Medical Genetics and Rare Diseases.
Speaking at the opening ceremony, Mr. Phan Huu Phuc (Deputy Director in charge of medical affairs at the Vietnam National Hospital of Pediatrics) warmly welcomed distinguished guests and colleagues from both within Vietnam and internationally. Mr. Phuc shared: "Medical genetics has been playing a crucial role in both clinical practice and research. Updating knowledge and sharing experiences through scientific conferences like this are essential."
Mr. Phan Huu Phuc (Deputy Director in charge of medical affairs at the Vietnam National Hospital of Pediatrics) delivers the opening speech at the conference.
Through this conference, Mr. Phuc expressed his hope to foster more opportunities for scientific research collaboration and international cooperation in the field of Pediatrics, aiming to help Vietnamese physicians stay abreast of the latest advancements worldwide.
The 4th Vietnam - US Conference on Medical Genetics and Rare Diseases boasts a comprehensive agenda, focusing on five key themes:

Cancer Genetics and Preimplantation Genetic Testing (PGT)
Complete Genome/Exome Sequencing for Rare and Undiagnosed Diseases; Enzyme Replacement Therapy
The Power of Complete Genome Sequencing - Discovering Novel Variants in Precision Medicine
Training in Medical Genetics; Monogenic Diseases and Gene Therapy
Genetic Counseling and Prenatal Diagnosis

The speakers and chairs participating in the conference are all leading experts with extensive experience in Vietnam, alongside renowned pediatric specialists from the University of Washington. This conference serves as an invaluable opportunity for delegates and physicians to update their knowledge and exchange experiences on cutting-edge techniques implemented in the diagnosis and treatment of genetic and rare diseases.
Pham Dinh Minh, representing GENTIS, participates in the conference.
As a co-organizer of this year's conference, GENTIS showcased its comprehensive genetic testing ecosystem for the Vietnamese population, utilizing next-generation sequencing technology. Notably, this technology is playing a vital role in assisting clinicians in accurately diagnosing and treating patients with rare diseases.
With the goal of providing the best genetic analysis solutions for reproductive health for patients and doctors in Vietnam, GENTIS has continuously researched, developed, and applied PGT-M technology for preimplantation genetic testing for rare diseases. Not only effective in diagnosing Thalassemia, PGT-M also aids in diagnosing many other rare single-gene disorders in embryos, such as spinal muscular atrophy, Duchenne muscular dystrophy, Hemophilia, achondroplasia, congenital adrenal hyperplasia, spherocytosis, Marfan syndrome, autosomal dominant polycystic kidney disease, aniridia, congenital deafness, and more.
With a laboratory system that meets ISO 9001:2015 and ISO 15189:2012 standards in Hanoi and Ho Chi Minh City, and the capacity to perform tens of thousands of tests annually, GENTIS remains committed to developing genetic technologies tailored to the Vietnamese population, bringing significant value to the diagnosis and treatment of rare diseases in particular and diseases in general. Notably, GENTIS is increasingly asserting its leading position in the field of genetic analysis, maintaining the complete trust of its valued customers and partners.
            [content_more] => 
            [meta_title] => Rare Diseases - A Major Challenge for Medicine in Diagnosis and Treatment
            [meta_description] => Genetic disorders, undiagnosed and rare diseases are on the rise globally.
            [meta_keyword] => assisted reproduction,gentis,rare diseases,pgtm
            [thumbnail_alt] => 
            [post_id] => 1195
            [category_id] => 4
        )

    [6] => stdClass Object
        (
            [id] => 1194
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-7684.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-03-28
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-03-28 15:27:13
            [updated_time] => 2024-09-04 13:58:30
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => The-marvelous-discoverties-of-assisted-reproductive-technology
            [title] => The Marvelous Discoveries of Assisted Reproductive Technology
            [description] => The development of the assisted reproductive technology (ART) field has opened a new era for infertile couples. Notably, the success rate of ART techniques is greatly influenced by accompanying technologies such as embryo screening tests and ovarian rejuvenation.
            [content] => 
GENTIS constantly approaches, researches, and develops new tests, especially clinical applications in ART, to provide accurate, fast, and effective results to help clinicians best treat patients.
Prof. Dr. Nguyen Dinh Tao - Chairman of Hanoi Association of ART
At the 2nd Scientific Conference and Congress for the 2024-2029 term held on March 24, leading experts updated the latest scientific information in the field of ART.  A highlight was the presentation by MSc. Nguyen Quang Vinh (Director of GENTIS Laboratory Center) on the topic "Application of PGT-Max 1 test in screening embryos carrying common microdeletions."
According to MSc. Vinh, PGT-Max 1 is a breakthrough improvement over conventional preimplantation genetic testing (PGT). The advantage of this test is that, in addition to being able to detect aneuploidy of 24 chromosomes, chromosomal structural abnormalities (microdeletions, duplications) with a size of more than 5Mb, and mosaic embryos (20% - 80%), it can also detect additional chromosomal structural abnormalities with a smaller size of more than 2Mb related to some common genetic diseases/syndromes such as:

22q11.2 deletion (associated with DiGeorge syndrome)
1p36 deletion (associated with 1p36 deletion syndrome)
Some other common microdeletions/microduplications

MSc. Nguyen Quang Vinh (Director of GENTIS Laboratory Center) presents on the topic "Application of PGT-Max1 test in screening embryos carrying common microdeletions."
GENTIS has successfully optimized and applied the PGT-Max 1 test on embryos for many infertile couples wishing to have children. Thanks to the PGT-MAX 1 test, doctors and experts can select embryos with good genetic quality, increasing the chances of pregnancy when performing in vitro fertilization (IVF), helping children to be born healthy and free from screened genetic abnormalities.
At GENTIS, the PGT-MAX 1 test is performed on the most advanced technologies such as NGS sequencers from Illumina USA, specialized bioinformatics software with the highest sensitivity and specificity of up to 99.9%,... "In the future, GENTIS will constantly improve and update new services in the field of assisted reproduction, helping to meet the needs of doctors and help many couples with genetic diseases to give birth to healthy children," MSc. Vinh shared.
According to experts, genetic testing is indispensable in assisted reproduction. However, not all clinicians have in-depth expertise in genetics. Therefore, it is difficult to advise patients to understand the method and limitations of genetic testing, explain cases of unsuccessful implementation, or advise on results after implementation, etc.
Therefore, the combination of clinicians, testing labs, and geneticists is essential to provide the best advice to patients. These issues were clearly shared by Nguyen Thi Huyen, MSc. MD. in the presentation "Genetic counseling in the era of Genomics and personalized treatment."
In the field of ART, genetic counseling plays an extremely important role. Accordingly, geneticists will calculate genetic risks, explain the inheritance pattern of the disease, advise on the principles, advantages, and limitations of testing methods, interpret test results, etc. Thereby, raising awareness and understanding of patients about their genetic risks and making decisions that are beneficial to themselves and their families. 
Nguyen Thi Huyen, MSc. MD. presents the report "Genetic counseling in the era of Genomics and personalized treatment"
Most importantly, it supports and advises clinicians, helping them to make the best testing and treatment decisions for patients. "With the mission of 'Improving the physical and intellectual well-being of Vietnamese people,' GENTIS always focuses on researching and developing genetic tests serving precision medicine... Thereby bringing modern solutions, accompanying and supporting doctors in taking care of the health of the community," MSc. Huyen shared.
Besides, the topic "Ovarian rejuvenation with platelet-rich plasma" by Dr. Dang Vinh Dung (108 Military Central Hospital) is also one of the issues of interest to many experts. According to Dr. Dung, the clinical application of platelet-rich plasma (PRP) has increased markedly in the past decade. PRP therapy is widely used in various fields of medicine, including assisted reproduction. PRP is produced from autologous blood samples with the advantages of being easy to perform, limiting the risk of infectious diseases, and immune reactions.
Dr. Dang Vinh Dung (108 Military Central Hospital) presents the report "Ovarian rejuvenation with platelet-rich plasma"
PRP therapy is a promising treatment option for women who want to restore or improve ovarian function and rejuvenation. The application of platelet-rich plasma to rejuvenate the ovaries has been applied in the world for about 2-3 years, especially in the last year, there have been many documents talking about this issue and showing very clear results. Dr. Dung also highly appreciated the effectiveness of the PRP IVF kit used to separate platelet-rich plasma that GENTIS is providing.
Through the reports at the 2nd Scientific Conference and Congress for the 2024-2029 term, GENTIS hopes to have contributed to providing useful knowledge for doctors and experts in the field of assisted reproduction as well as families wishing to have children. With over 13 years of experience, GENTIS will always develop, innovate, and update the best testing services to customers and partners for the mission of improving the physical and intellectual well-being of Vietnamese people.
            [content_more] => 
            [meta_title] => The Marvelous Discoveries of Assisted Reproductive Technology
            [meta_description] => The development of the assisted reproductive technology (ART) field has opened a new era for infertile couples
            [meta_keyword] => assisted reproduction,gentis
            [thumbnail_alt] => 
            [post_id] => 1194
            [category_id] => 4
        )

    [7] => stdClass Object
        (
            [id] => 1191
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => z5254489435139_77cf34b1509611521de1946265081e11.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2024-03-16
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2024-03-18 08:37:02
            [updated_time] => 2024-09-04 09:20:28
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Gentis-attending-the-grand-opening-of-Phuong-Nam-Hospital
            [title] => GENTIS attending the Grand Opening of Phuong Nam Hospital
            [description] => On March 16th, 2024, representatives from GENTIS, Mr. Do Manh Ha (General Director) and Mrs. Tran Thi Ha Dong (Deputy Director of the branch) visited and sent warmest congratulations and flowers on the official Grand Opening of Phuong Nam Hospital - a member of Phuong Chau Healthcare Group, located at No.2 Nguyen Luong Bang Street, Tan Phu Ward, District 7, Ho Chi Minh City.

            [content] => 

Phuong Nam Hospital was founded with the mission to deliver high-quality, international-standard healthcare services to the community. With a comprehensive ecosystem encompassing Obstetrics and Gynecology, Pediatrics, Infertility and IVF, General Medicine and Andrology, the hospital is dedicated to play an important role in multidisciplinary consultations and treatments with a closely linked process, fully supporting women's reproductive health issues and families.

With advanced medical facilities and modern infrastructure, as well as a team of experienced doctors and nurses, Phuong Nam Hospital is dedicated to providing patients with the highest quality and safest healthcare services.
GENTIS wishes Phuong Nam Hospital a successful start and sustainable development. Let's take a moment to appreciate the highlights of this special day. 

Với hệ thống trang thiết bị hiện đại, cơ sở vật chất khang trang cùng đội ngũ y bác sĩ giàu kinh nghiệm. Bệnh viện Phương Nam cam kết mang đến dịch vụ chăm sóc sức khỏe chất lượng và an toàn nhất cho quý khách hàng. 
GENTIS chúc bệnh viện có khởi đầu thuận lợi, phát triển vững bền. Hãy cùng GENTIS ngắm nhìn những khoảnh khắc ý nghĩa trong buổi khai trương này nhé!




            [content_more] => 
            [meta_title] => GENTIS attending the Grand Opening of Phuong Nam Hospital
            [meta_description] => On March 16th, 2024, representatives from GENTIS, Mr. Do Manh Ha (General Director) and Mrs. Tran Thi Ha Dong (Deputy Director of the branch) visited and sent warmest congratulations and flowers on the official Grand Opening of Phuong Nam Hospita
            [meta_keyword] => Gentis,Phuongnam,Grandopening
            [thumbnail_alt] => 
            [post_id] => 1191
            [category_id] => 4
        )

)